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Abstract
Background: Dampness and mold have been shown in qualitative reviews to be associated with a variety of
adverse respiratory health effects, including respiratory tract infections. Several published meta-analyses have
provided quantitative summaries for some of these associations, but not for respiratory infections. Demonstrating a
causal relationship between dampness-related agents, which are preventable exposures, and respiratory tract
infections would suggest important new public health strategies. We report the results of quantitative meta-
analyses of published studies that examined the association of dampness or mold in homes with respiratory
infections and bronchitis.
Methods: For primary studies meeting eligibility criteria, we transformed reported odds ratios (ORs) and
confidence intervals (CIs) to the log scale. Both fixed and random effects models were applied to the log ORs and
their variances. Most studies contained multiple estimated ORs. Models accounted for the correlation between
multiple results within the studies analyzed. One set of analyses was performed with all eligible studies, and
another set restricted to studies that controlled for age, gender, smoking, and socioeconomic status. Subgroups of
studies were assessed to explore heterogeneity. Funnel plots were used to assess publication bias.
Results: The resulting summary estimates of ORs from random effects models based on all studies ranged from
1.38 to 1.50, with 95% CIs excluding the null in all cases. Use of different analysis models and restricting analyses
based on control of multiple confounding variables changed findings only slightly. ORs (95% CIs) from random
effects models using studies adjusting for major confounding variables were, for bronchitis, 1.45 (1.32-1.59); for
respiratory infections, 1.44 (1.31-1.59); for respiratory infections excluding nonspecific upper respiratory infections,
1.50 (1.32-1.70), and for respiratory infections in children or infants, 1.48 (1.33-1.65). Little effect of publication bias
was evident. Estimated attributable risk proportions ranged from 8% to 20%.
Conclusions: Residential dampness and mold are associated with substantial and statistically significant increases
in both respiratory infections and bronchitis. If these associations were confirmed as causal, effective control of
dampness and mold in buildings would prevent a substantial proportion of respiratory infections.
Background
Dampness and mold in buildings have been associated
in many studies with adverse respiratory health effects.
A number of qualitative summaries of this literature are
available [1-3]. In their review, the Institute of Medicine
(IOM) of the National Academy of Sciences found
sufficient evidence to document an association between
qualitatively assessed indoor dampness or mold and
upper respiratory tract symptoms, cough, wheeze, and
asthma symptoms in sensitized persons [2]. A later
review by the World Health Organization (WHO),
including additional studies, expanded the documented
associations to include asthma development, current
asthma, dyspnea, and respiratory infections. While both
reviews concluded that excessive indoor dampness was
an important public health problem meriting prevention
and remediation, neither review produced quantitative
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and specific health outcomes.
Two prior quantitative meta-analyses have been pub-
lished on indoor dampnes sa n dm o l da n ds e l e c t e d
health effects. In 2007, Fisk et al. [4] quantitatively sum-
marized the associations of home dampness and mold
with a set of respiratory and asthma-related health
effects, based on available studies published in peer-
reviewed journals in English [4]. Health outcomes
included were upper respiratory tract symptoms, cough,
wheeze, asthma diagnosis ever, current asthma, and
asthma development. The meta-analyses produced cen-
tral estimates of ORs ranging from 1.34 to 1.75 for
these health outcomes, with 95% confidence intervals
(CIs) excluding the null in nine of ten instances. Antova
et al. [5] analyzed pooled data from 12 European cross-
sectional studies of visible mold in residences and
respiratory or allergic health outcomes of children. Out-
comes included bronchitis, wheeze, asthma, nocturnal
dry cough, morning cough, sensitivity to inhaled aller-
gens, hay fever, and “woken by wheeze.” Central esti-
mates of ORs ranged from 1.30 to 1.50, with all 95% CIs
excluding the null.
Thus while prior non-quantitative reviews have
reported consistent associations between dampness or
mold and respiratory infections, no quantitative meta-
analysis of this relationship has been reported. A sub-
stantial number of epidemiologic studies on dampness
or mold and respiratory infections are available for this
purpose.
Respiratory (tract) infections are generally considered
to include infections of the lower and upper respiratory
tract, and otitis media. Lower respiratory tract infections
include pneumonia, acute bronchitis, and acute exacer-
bation of chronic bronchitis. While acute bronchitis is
generally caused by an infection, chronic bronchitis is
generally non-infectious in origin. Upper respiratory
tract infections are acute infections of the nose, sinuses,
and throat. Otitis media, an infection or inflammation
o ft h em i d d l ee a ro f t e nr e s ulting from a prior upper
respiratory tract infection, can be bacterial or viral in
origin.
The burden of morbidity and mortality and the finan-
cial costs of respiratory tract infections are enormous.
Little effective prevention is currently possible outside of
two strategies: attempting to avoid contact with or
spreading of infectious agents in aerosols, droplets, or
surfaces, such as by hand washing, avoiding infected
individuals, avoiding face-touching, and covering
sneezes; and vaccination for influenza and pneumococ-
cal pneumonia. It is important to determine whether
avoidance of dampness and mold can provide another
means of reducing respiratory tract infection. As a
step toward that goal, we performed a quantitative
meta-analysis to summarize findings in the peer-
reviewed medical literature on associations between
dampness or mold in residences and respiratory tract
infections or bronchitis.
Methods
Our search for published articles involved several strate-
gies (see details in Additional File 1, Appendix 1): an
online search of PubMed, an online search of the jour-
nal Indoor Air, and a manual search of the reference list
in the publication “World Health Organization Guide-
lines on Dampness, Mold, and Health” [3].
Papers meeting all of the following criteria were
selected for use in the meta-analyses:
1) published in a refereed archival journal in English.
2) based on original data; i.e., not a review article or
meta-analysis.
3) reported effect estimates as odds ratios (ORs) or
risk ratios (RRs), with confidence intervals (CIs) esti-
mated from statistical analyses.
4) included as risk factors qualitatively assessed
dampness, mold, or dampness and mold in resi-
dences, whether in detached homes or multifamily
housing (dormitory rooms were accepted as homes)
5) included one or more of the health outcomes
listed in Table 1 (see below).
6) included at least ten buildings, if building-level
exposures were used.
W ep e r f o r m e do n es e to fa n a l y s e si n c l u d i n go n l y
results from studies that controlled for potential con-
founding by the following factors via study design or
analysis method: age, gender, smoking (e.g., active smok-
i n g ,s m o k i n gi nh o m e ,s m o k i n gb ym o t h e rd u r i n gp r e g -
nancy), and some measure of socioeconomic status
(SES). We considered studies with populations limited
to home owners, university students, or university
employees as adequately controlled for SES. We also
considered the reporting of no significant association
between an outcome and a potential confounder as
equivalent to controlling for that confounder. In another
set of unrestricted analyses, we did not require control
for these potential sources of confounding, although
most of the added studies controlled for all but one of
these factors.
For papers which reported strength of association as
RRs instead of ORs, we included RRs as if they were
ORs for the primary analysis. RRs approximate ORs well
when outcome prevalence is low; however, we also per-
formed an analysis excluding RR values.
Ideally, a meta-analysis would utilize input data only
from studies with the same precisely defined risk factor,
health outcome, and population. As this was not
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similar as practicable, all in residences. The following
risk factors were accepted: dampness, water damage,
visible mold, mold odor, or flooding - all in the whole
home, main living area, or bedroom. We did not distin-
guish among dampness, mold, dampness or mold,
and dampness and mold as risk factors. Our rationale -
visible mold is always considered the result of excess
dampness whether or not the dampness is reported, and
excess dampness is very often accompanied by mold,
although the mold may not be visible. Thus, it was not
possible to make a clear distinction among these risk
factors. Excluded as inputs were ORs for condensation
(a less certain indication of potential microbial contami-
nation), ORs per unit area of visible mold or water
damage, ORs for “suspected moisture problem,” and
ORs for higher measured airborne concentrations of
m o l d s ,b a c t e r i a ,e r g o s t e r o l ,g l u c a n ,o re n d o t o x i n .T h e
included studies had either adults or children as sub-
jects. Presence of dampness and/or mold was deter-
mined in each study by either the occupants or the
researchers. We did not distinguish between occupant-
reported dampness and/or mold and researcher-
reported dampness and/or mold.
The categories of health outcomes constructed for
meta-analyses were respiratory infection group, respira-
tory infection group excluding otitis media, and bron-
chitis (acute, chronic, or not clearly characterized as
acute or chronic). The respiratory infection group out-
comes involved viral or bacterial infections; we excluded
from consideration respiratory infections by fungi which
occur primarily in people with compromised immune
systems. The respiratory infection and bronchitis out-
come categories overlap, with some studies of respira-
tory infections including bronchitis or episodes of
bronchitis within their definition of a respiratory infec-
tion. We included separate bronchitis outcomes in the
respiratory infection group only if the definition stated
or suggested acute bronchitis. The category of bronchitis
includes acute bronchitis, normally the result of an
acute respiratory infection, and chronic bronchitis,
which may be unrelated to an infection. Most papers
did not provide sufficient information to allow classifica-
tion of the bronchitis as acute or chronic.
For respiratory infections, we also produced summary
estimates separately for studies of children and of adults
(omitting the one study that included both). In addition,
we produced a summary estimate for the respiratory
infections group after excluding findings for a set of
relatively nonspecific upper respiratory outcomes that
seemed most susceptible to inclusion of allergic or irri-
tant symptoms. This excluded findings such as for com-
mon cold, chest cold with wheeze, acute upper
respiratory infections, acute respiratory tract infections,
respiratory infections, and airway infections. We did not
exclude throat infections, sinusitis, tonsillitis, otitis, or
the various lower respiratory infections.
We applied random effects models [6] to derive cen-
tral estimates and confidence limits for associations of
the health outcomes with dampness and mold as
reported by the multiple published studies which varied
in symptom definitions, subjects, and locations. The
approach used was the same as in a prior meta-analysis
of dampness and mold with respiratory and asthma out-
comes [4]. In each meta-analysis model, we included
multiple ORs from single studies that reported more
than one OR for different but correlated risk factors (e.
g., visible mold; dampness), different health outcomes
(e.g., respiratory infection, common cold), or both; e.g.,
ORs in one study for visible mold with bronchitis,
Table 1 Health outcomes from reviewed studies, grouped into outcome categories used in meta-analyses
Category in
Meta-Analysis
Number of
studies
Outcomes from Individual Studies Included in Each Category
Bronchitis (all: acute or chronic) 13 bronchitis, bronchitis in the prior year, current bronchitis, obstructive bronchitis, chronic
bronchitis; doctor diagnosed bronchitis in the past year; bronchitis indicated by cough
and phlegm ≥ 3 months for at least two consecutive years, bronchitis times per year
Respiratory infection group 19 airway infection last month; sinus or ear infection with antibiotic use; cold; common
cold; > 4 (or > 6) colds in last 12 months; frequent childhood respiratory infections;
sinusitis; tonsillitis; acute upper respiratory tract infection in past 12 months;
tonsillopharyngitis, croup, bronchitis, or bronchiolitis diagnosed by doctor; chest cold;
consulting general practitioner for acute respiratory tract infection (with wheeze); sum
of episodes of tonsillitis, sinusitis, otitis, bronchitis; one or more episodes of bronchitis
or pneumonia; tonsillitis, otitis media, sinusitis, bronchitis, or pneumonia at least once;
chest cold with wheeze; otitis media; pneumonia; bronchitis times per year
Respiratory infections excluding otitis media 17 same as listed in cell above excluding otitis media
Respiratory infection group excluding
nonspecific upper respiratory infection
15 sinus or ear infection with antibiotic use; sinusitis; tonsillitis; tonsillopharyngitis, croup,
bronchitis, or bronchiolitis diagnosed by doctor; sum of episodes of tonsillitis, sinusitis,
otitis, bronchitis; one or more episodes of bronchitis or pneumonia; tonsillitis, otitis
media, sinusitis, bronchitis, or pneumonia at least once; otitis media; pneumonia;
bronchitis times per year
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infections, and dampness with respiratory infections.
Random effects models adjusting for possible within-
study correlations were used in our primary analyses. In
addition, we used the procedure PROC MIXED in SAS
(ver 9.2, SAS Institute Inc., Cary, NC), which allows fix-
ing the within-study variances (matrix R in SAS) while
estimating between-study variance (matrix G in SAS).
ORs and 95% CIs reported in each reviewed study
were first transformed to the log scale. The transformed
results for each outcome category were then combined
using a random effects model. The model accounting
for the correlation between multiple results within stu-
dies was
yN ij i ij ~( , )   00 +
2 (1)
where:
yij is the ln OR in the jth sub-study of the ith study;
b0 is the fixed effect across all studies;
b0i is the random effect in the ith study. b0i ~ N(0,
s*
2), where:
s*
2 is the between-study variance; and
 ij
2 is the within-study variance, calculated from the
log CI.
Results based on the model described above were
compared to those obtained from secondary analyses
using fixed effects models that assumed independence
of multiple ORs within individual studies. Additional
models were constructed that omitted the reported RR
values. For final models, we assessed heterogeneity of
study-specific effect estimates using the meta command
in STATA to estimate the Q statistic and associated
p - v a l u e .W h e r et h ep - v a l u ef o rh e t e r o g e n e i t yw a s< 0 . 0 5
for both the full and restricted sets of findings, we
further explored possible sources of heterogeneity by
conducting sensitivity tests, and performing tests of het-
erogeneity for various subsets of findings, as feasible.
Funnel plots were produced to check for evidence of
publication bias. If the plot for an outcome showed asym-
metry only among less precise (generally smaller) studies,
suggesting that smaller studies without positive findings
were less likely to have been published, then an alternate
analysis was performed. This excluded the set of smaller
studies exhibiting asymmetry, in order to produce pre-
sumably less biased summary estimates based only on
the more completely reported, more precise studies.
Results
Overall, 23 studies were selected for inclusion in these
meta-analyses. Table 1 provides the number of studies
for each health outcome category and the specific out-
comes from reviewed studies included in each category.
Table 2 identifies the studies in each health outcome
category. It was not possible to summarize findings for
acute bronchitis separately, as too few studies reported
findings for an outcome clearly restricted to acute or
infectious bronchitis.
Major results from the meta-analyses of all eligible
studies, regardless of control for confounding, are pro-
vided in column 2 of Table 3. For the two primary out-
comes, bronchitis and respiratory infections, central
estimates of ORs were 1.44 and 1.45. For these and all
other subcategories in Table 3, 95% CIs excluded the
null. P-values for heterogeneity for both were <0.0001.
For bronchitis and the respiratory infection group, cen-
tral estimates changed little (by less than 0.01) when the
models were restricted to studies that controlled for age,
gender, smoking, and socioeconomic status (column 3);
however, with this restriction the p-value for heteroge-
neity for bronchitis increased to 0.12. Estimates (not
shown) derived from fixed effects models were also very
similar to the estimates in Table 1 - the maximum
change in central estimate OR was 0.04. For the respira-
tory infection group, excluding RR values reported by
two studies [7,8] changed the central estimate by
less than 0.01 and confidence interval endpoints by 0.03
or less.
A series of models excluding each finding sequentially
did not identify highly influential single findings. The
two most extreme findings (ORs of 0.48 [9] and 5.1
[10]) were not from large studies, and did not have
major influence. Additional models were constructed
with specific subgroups of respiratory infection out-
comes (Table 3). For these subgroups, when restricted
to studies with control of at least the four key con-
founding factors, modeling outcomes of respiratory
infections excluding otitis media did not much change
the estimate or decrease heterogeneity. Modeling out-
comes of respiratory infections excluding common cold
and nonspecific upper respiratory infections increased
the central estimate to 1.50 and decreased heterogeneity
(p = 0.07). Restricting the model to only common cold
or acute upper respiratory infection (excluding several
findings of unspecified respiratory infections), the cen-
tral estimate was 1.38, but with high heterogeneity. Con-
structing separate overall respiratory infection group
models for children/infants and for adults led to similar
ORs of 1.48 and 1.49, with decreased heterogeneity (p =
0.09) only for children/infants. Other study factors
potentially contributing to heterogeneity included statis-
tical adjustment for subject atopy, parental atopy, or
presence of furry pets, and whether assessment of envir-
onmental dampness was conducted by researchers or
participants. Numbers in these subgroups were small,
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Study Health
Outcomes
#
Study Type Number of Subjects^ Controlled
for Age, Sex,
Smoking and
Socioeconomic
Status
Bakke et al. 2007 [29] RI cross sectional 173 Yes
Biagini et al. 2006 [10] RI birth cohort 585 Yes
Brunekreef et al. 1989 [30] B cross sectional 4,625 Yes
Dales et al. 1991 [31] B cross sectional 13,495 No
Diez et al. 2003 [32] B birth cohort 172 – 178 No
du Prel et al. 2006 [33] RI, B cross sectional 5,757 – 20,059 Yes
Ekici et al. 2008 [34] RI, B cross sectional 9,610 – 9,853 Yes (BR)
No (RI)
Haverinen et al. 2001 [8] RI, B cross sectional 1,017 Yes
Karevold et al. 2006) [35] RI cross sectional 275 – 737 Yes
Kilpelainen et al. 2001 [36] RI cross sectional 9,765 – 10,504 No
Koskinen et al. 1999 [37] RI, B cross sectional 57 – 147 No
Li and Hsu 1996 [38] RI, B cross sectional 1,340 Yes
Pettigrew et al. 2004 [39] RI* birth cohort 806 No
Pirhonen et al. 1996 [40] RI, B cross sectional 1,460 Yes
Rylander and Megevand 2000 [41] RI, B** cross sectional 304 No
Spengler et al. 1994 [42] B cross sectional 12,842 No
Spengler et al. 2004 [43] RI, B cross sectional 5,951 Yes
Stark et al. 2003 [7] RI birth cohort 499 Yes
Strachan 1988 [44] RI cross sectional 873 No
Sun et al. 2009 [45] RI cross sectional 3,436 Yes
van Gageldonk-Lafeber et al. 2007 [9] RI case-control 626 No
Yang et al. 1997 [46] RI, B cross sectional 4,164 Yes
Yang et al. 1999 [47] RI* case control 438 Yes
# RI = respiratory infection group, B = bronchitis (acute, chronic, or uncharacterized as acute or chronic), * Outcome is otitis media, most often accompanied by
an upper respiratory infection
^ used for inputs to meta-analyses ** Bronchitis times per year assumed to be acute/infectious bronchitis
Table 3 Key results of the meta-analyses, with results of tests for heterogeneity
Health Outcome All Studies Studies Controlling for All Four Key Confounders
Summary
Estimate OR
(95% CI)
p-Value
Hetero-
geneity
Summary
Estimate OR
(95% CI)
p-Value
Hetero-
geneity
Attributable Risk
Proportion
#
Bronchitis 1.45
(1.34 - 1.56)
<0.0001 1.45
(1.32 - 1.59)
0.12 8.3 - 18.4%
Respiratory infection group 1.44
(1.32 - 1.58)
<0.0001 1.44
(1.31 - 1.59)
<0.0001
Respiratory infections excluding otitis media 1.43
(1.31 - 1.56)
<0.0001 1.40
(1.29-1.52)
<0.0001
Respiratory infections excluding common cold and
nonspecific upper respiratory infections
1.42
(1.26 - 1.60)
0.01 1.50
(1.32 - 1.70)
0.07 9.1 - 20%
Common cold or acute upper respiratory infection 1.38
(1.21 - 1.57)
0.009 1.38
(1.13 - 1.67)
0.002
Respiratory infections (children or infants) 1.48
(1.34 - 1.62)
0.16 1.48
(1.33 - 1.65)
0.09 8.8 - 19.4%
Respiratory infections (adults) 1.50
(1.22 - 1.83)
<0.0001 1.49
(1.14 - 1.95)
<0.0001
# estimated for findings restricted to studies controlling for four key confounders and assuming a range of 20-50% of houses with dampness or mold; provided
only for estimates with p-value for heterogeneity >0.05.
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to influence heterogeneity.
Figure 1 shows forest plots with adjusted ORs and
95% CIs for the associations of respiratory infections
and bronchitis with dampness and mold as reported in
the original studies. Figure 1 also shows the summary
estimates produced in the meta-analyses using random
effects models with all studies listed in Table 2.
Funnel plots for the respiratory infection group and
bronchitis are shown in Figure 2. No asymmetry was
evident for bronchitis. The asymmetry in data points for
the respiratory infection group, i.e., the absence of pub-
lished ORs less than 1.0 produced by less precise (gener-
ally smaller) studies, suggested possible publication bias.
When we excluded study results with standard errors
greater than 1.0 (the set with asymmetric estimates), the
r e v i s e de s t i m a t ef o rt h i so u t c o m ed i f f e r e db yo n l y0 . 0 1
from the estimate in Table 1, suggesting that publication
bias had little effect on the central estimates.
Discussion
The results of these meta-analyses indicate that building
dampness and mold are associated with moderate but
statistically significant increases in respiratory infections
and bronchitis. The central estimates and confidence
limits for these associations were stable across different
modeling strategies: adding studies that controlled for
fewer confounding variables, assuming independence of
multiple estimates from the same studies, and omitting
included RRs. Also, analyses suggest that publication
bias likely had little impact on these estimates.
The statistical associations reported here do not docu-
ment that dampness and mold are causally related to
the bronchitis and respiratory infections. Building damp-
ness itself is unlikely to directly cause adverse health
effects. If these associations are confirmed as causal,
exposure to one or more dampness-related agents,
either microbiologic or chemical, is likely to be ulti-
mately implicated. However, the consistent evidence of
adverse health effects from a substantial number of stu-
dies that have controlled for key potential confounders,
along with the moderately strong associations and the
limited evidence of publication bias, provide initial evi-
dence for causal links between these health effects and
some dampness related agent(s).
Evidence for relationships of dampness or mold with
respiratory infections and bronchitis has strengthened –
initially anecdotal, now documented in multiple observa-
tional studies. Within the past decade, there have been
at least three major qualitative reviews of the associa-
tions of dampness and mold with health outcomes. An
interdisciplinary Nordic review panel in 2001 [11] con-
cluded “There also seems to be an association between
dampness and.... airway infections.” but this review pro-
vided no conclusions pertaining to the association of
dampness with bronchitis. The IOM review in 2004 [2]
made no conclusions relative to the association of
dampness or mold with respiratory infections or bron-
chitis, but stated “Healthy persons exposed to dampness
or moldy indoor environments sometimes report that
t h e ya r em o r ep r o n et or e s p i r a t o r yi n f e c t i o n s . . . . ” The
most recent review, by WHO in 2009 [3], concluded
Figure 1 Odds ratios and confidence intervals from all studies meeting the less restricted eligibility criteria and from a meta-analysis
of these studies performed using the random effects model and assuming dependent estimates within studies. The width of the boxes
(some so small they appear as points) is proportional to the precision of the study and the ends of the horizontal lines represent lower and
upper 95% confidence limits. The left vertical line marks an odds ratio of 1.0, corresponding to no increased risk, while most of the reported
odds ratios are greater than unity indicating an increase in risk with dampness and mold. The central estimate from the meta-analysis is
indicated by the right vertical line and the left- and right-side points of the diamond at the bottom of the figure indicate the lower and upper
95% confidence limits from the meta-analyses.
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tion of dampness and dampness-related agents with
respiratory infections, but only limited or suggestive evi-
dence of an association for bronchitis. The results of the
present quantitative meta-analyses are consistent with
the WHO findings for respiratory infections, but imply
more strongly that dampness and mold are associated
with bronchitis.
Prior quantitative meta-analyses on health effects of
dampness and mold have not included a category for
respiratory tract infections overall. The meta-analysis by
Antova et al. [5] on visible mold in residences and bron-
chitis in children, based on a set of similar European
studies, reported an OR (95% CI) of 1.38 (1.29-1.47).
This compares well to the summary OR reported here
for dampness or mold in residences and bronchitis,
based on the larger medical literature, of 1.45 (1.32-
1.59).
The outcome categories included in this review con-
tain a variety of specific diseases, with all but chronic
bronchitis caused by a range of infectious organisms.
We will consider biologic plausibility of the associations
reviewed here separately for the infectious and non-
infectious mechanisms.
Respiratory infections include upper and lower
respiratory tract infections and otitis media. Upper
respiratory tract infections include common colds, phar-
yngitis (sore throat), and sinusitis. Most are caused by
viruses such as rhinovirus, coronavirus, adenovirus, or
respiratory syncytial virus, although a minority of cases
is caused by bacteria [12]. Otitis media, an infection or
inflammation of the middle ear often resulting from a
prior upper respiratory tract infection, can be bacterial
or viral in origin [13].
Lower respiratory tract infections, including pneumo-
nia, acute bronchitis, and acute exacerbation of chronic
bronchitis, can result from a variety of causal organisms,
including Haemophilus influenza, Streptococcus pneumo-
niae,a n dMoraxella catarhalis [14]. Pneumonia is an
inflammation of the lung, caused usually by an infection
from bacteria, virus, or fungi, but sometimes by acciden-
tal inhalation of other substances [15]. Bronchitis, an
inflammation of the mucus membranes of the bronchi,
can be acute or chronic. Acute bronchitis often occurs
in conjunction with viral infections such as common
cold (e.g., rhinovirus, adenovirus), respiratory syncytial
virus, or influenza, with a minority of cases caused by
bacterial infections. In contrast, chronic bronchitis is
generally caused not by respiratory infection, but by
recurring injury or irritation to the lining of the bronchi,
such as from tobacco smoke or irritating dust or fumes
[16].
An evident increase in respiratory infections in asso-
ciation with dampness or mold could occur from
increased numbers of infections, or from more serious
infections that are more clinically apparent; either might
result from impairment of immune defenses. Although
the specific exposures occurring in the reviewed studies
are not known, and although it has not been demon-
strated that exposures to microbial toxins in typical
damp or moldy houses can suppress immune response
in humans, potential underlying mechanisms can be
suggested. Studies both in vitro and in vivo have
demonstrated inflammatory and immunosuppressive
responses to the spores, metabolites, and components of
specific microorganisms found in damp buildings [2,3].
Repeated activation of immune responses and inflamma-
tion from microbiologic exposures may contribute to
Figure 2 Funnel plots for bronchitis and the respiratory infection group. The horizontal line in the plot for the Respiratory Infection Group
indicates the line (Standard Error = 1) below which asymmetric data points were omitted in a secondary analysis.
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inflamed mucosal tissue may provide a diminished bar-
rier to respiratory infections. Observed synergistic inter-
actions in toxicologic studies among microbial agents
present in damp buildings, including specific fungi, acti-
nomycetes, and amoebae (e.g. [17,18]) suggest that
immunotoxic effects of fungal and bacterial strains typi-
cally found in damp buildings may be potentiated dur-
ing joint exposures. This could explain lack of evident
associations for specific exposures. Thus, some biologic
plausibility is evident even in the absence of consistent
associations between human exposures to specific
microorganisms or microbial components or products
and respiratory infections in healthy individuals.
For chronic bronchitis, more often caused by chronic
exposures to irritants and inflammatory agents, the
immunostimulatory and inflammatory agents and aller-
gens in some molds and other dampness-related micro-
bial agents may explain or contribute to the associations
[2,3]. Also, dampness in building materials can increase
the emission rates and indoor concentrations of some
chemicals [2], such as formaldehyde, which could cause
irritation or inflammation [19,20].
Our analysis is subject to multiple limitations. Publica-
tion bias in the selection of available studies remains a
possibility despite the limited evidence of publication
bias effects described above. Estimates from random
effects models should be interpreted with caution when
the number of observations is small, as in some sub-
analyses reported here. The test of heterogeneity used
here has low power to reject the null hypothesis when
the number of included findings is small.
The respiratory infections category used in this analy-
sis is broad, including outcome definitions of various
types of lower respiratory infections that include acute
bronchitis; common cold; mixes of lower and upper
respiratory infections; and upper respiratory infections
including otitis. There were not sufficient numbers of
most outcomes for separate analyses. We have sepa-
rately estimated summary measures of effect for bron-
chitis (acute or chronic), respiratory infections overall,
and various subsets of respiratory infections. It is possi-
ble that some disease caused by allergy or irritation,
especially in the upper respiratory tract, was classified
erroneously as respiratory infection. Since allergy and
irritation are known to be associated with damp indoor
spaces, this could have resulted in erroneously linking
dampness and mold with respiratory infections. To
check this possibility, we estimated risks for a restricted
set of respiratory infections: including lower respiratory
infections plus specific upper respiratory infections of
tonsillitis, pharyngitis, sinusitis, and otitis, but excluding
common cold and less specific upper respiratory
infections (e.g., acute upper airway infections, airway
infection, and frequent childhood respiratory infections),
with the highest potential of being allergic or irritant
outcomes misclassified as infections. Because this
restriction of the respiratory infection outcomes
increased the summary OR slightly from 1.44 to 1.50
(and reduced heterogeneity of findings), this potential
misclassification is not likely to explain the elevated risk
of infections found here with dampness or mold.
Regarding the summary OR of 1.38 for common cold
and acute upper respiratory infections, it is not clear
how much allergic and irritant effects have been
included with true upper respiratory infections. We did
not estimate effects for a category of lower respiratory
infections because these findings were mostly for acute
bronchitis. There were only seven findings for pneumo-
nia from three studies (ORs 0.79, 1.30, 1.33, 1.71, 1.77,
1.85, and 2.3), too few to allow confidence in a meta-
analysis (estimated summary OR = 1.57), but suggestive
of increased risk.
The substantial diversity of findings in the studies
reviewed here was evident in the initial low p-values for
heterogeneity. When acute bronchitis findings were
restricted to studies adjusted for the four key confound-
ing variables, the p-value for heterogeneity increased to
0.12. This suggests that heterogeneity for the unrest-
ricted findings may have been due to scattered estimates
from less well-adjusted studies. That the central OR
estimate, 1.45, remained unchanged with this restriction
suggests scatter in the unrestricted findings rather than
systematic bias.
For the respiratory infection group, restriction to find-
ings from more consistently adjusted models omitted
many of the most extreme estimates (e.g., 0.48, 0.49, 4.4,
4.8), but did not decrease heterogeneity of the remaining
findings. Exclusion of relatively nonspecific upper
respiratory infections, which might be misdiagnosed
allergic or irritant effects, increased the central estimate
to 1.50 and decreased heterogeneity (p = 0.07), whereas
the estimate for common cold or acute upper respira-
tory infection was 1.38. While substantial heterogeneity
remained within many of the subgroups listed in Table 3,
for those subgroups with little heterogeneity within, dif-
ferences in OR were not large.
Because of the small number of available studies and
the frequent use of outcomes containing multiple dis-
eases, clear conclusions cannot be drawn about even
associations with specific infectious diseases such as
influenza. While the central estimate for common cold
or acute upper respiratory infection of OR = 1.38, the
lack of homogeneity in the included findings and the
uncertain diagnosis makes this estimate only suggestive.
Most studies included here relied on occupant report-
ing of dampness and mold, a possible source of both
systematic bias and error. However, two prior reviews
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building occupants in dampness studies might have
positively biased the findings. The prior comparison by
Fisk et al. of occupant-reported versus independent
researcher-based assessments of dampness and mold in
six studies [4] concluded that it is “very unlikely that the
observed association of respiratory health effects with
dampness and mold is a consequence of over-reporting
of dampness and mold by occupants with respiratory
symptoms.” Bornehag et al. [11] reported that findings
of studies with independent assessment of both damp-
ness and health effects were similar to findings of stu-
dies with more subjective information sources.
The use of subjective, qualitative assessments of
dampness and mold, even if not systematically biased,
will misclassify actual causal exposures. However, these
subjective metrics are currently the most useful corre-
lates of health effects. Direct causal exposures related to
d a m p n e s sa n dm o l dh a v en o ty e tb e e nd o c u m e n t e d .
Many quantified assessments of microbial exposures
have been studied, and they have not shown consistent
associations with specific health effects in healthy indivi-
duals [3]. This is likely because the specific causal expo-
sures involved have either not yet been identified or not
been well measured. Also, as Antova et al. say, visible
molds “may better represent long-term exposure to
moulds than direct measurements during a short sam-
pling time [5].”
T h em a j o r i t yo fu n d e r l y i n gd a t aa r ef r o mc r o s ss e c -
tional studies that are subject to confounding and other
limitations inherent in that study design, despite the
attempts to control for known confounders. The result-
ing estimates are all less than 1.5, making their eleva-
tions especially susceptible to alternate explanation by
unmeasured confounding factors and other biases rather
than by dampness- or mold- related exposures. It is not
clear what additional confounding variables might
explain these findings consistently across studies. On
the other hand, since the risk factors assessed in these
studies are likely to be surrogates for unmeasured
indoor dampness-related causal exposures, ORs for the
true causal exposures would be higher.
The primary summary estimates reported here
required that studies controlled at least for age, gender,
smoking, and SES (although many included studies also
controlled for other factors). If studies did not ade-
quately control for all important confounders, biased
estimates may have resulted. Evidence suggesting that
substantial residual bias was unlikely comes from the
paper by Antova et al. [5]. Only two of the 23 studies
included here were among the 12 included in Antova et
al. Yet findings for bronchitis here and in the pooled
data analysis of over 58,000 children by Antova et al
were very similar, even though Antova et al. adjusted for
13 potential confounding factors - age, gender, current
smoker in household, maternal smoking during preg-
nancy, maternal and paternal education, household
crowding, nationality, gas cooking, unvented gas/oil/ker-
osene heaters, birth order, “ever had a pet,” and study
a r e a .A l s o ,t h ea n a l y s i sb yA n t o v ae ta l . ,w h e na d j u s t e d
only for age, gender, and geographic area, gave similar
estimates as when adjusted for many factors. Although
the estimates included in Antova’s summary for bron-
chitis had significant heterogeneity, estimates from all
included studies exceeded 1.0, and CIs for nine of the
10 exceeded 1.0. Furthermore, Antova et al. performed a
sensitivity analysis on potential heterogeneity on other
variables such as season of questionnaire, age of subject,
year of study, and response rate, and found little effect
o t h e rt h a nas i g n i f i c a n t l yh i g h e rO R sf o rb r o n c h i t i si n
studies with above 80% response. Overall, this suggests
that the relationships of bronchitis and various other
respiratory outcomes to mold are not much confounded
by the most obvious variables, and are not modified
substantially by other key variables.
Respiratory tract infections, the most common infec-
tious diseases in humans, have large health and cost
consequences for individuals and for the public. Acute
lower respiratory infections are the leading cause of
death in children below five years old worldwide [14].
Community-acquired pneumonia (e.g., not hospital-
acquired or in the immunosuppressed) is a major
cause of hospitalization and morbidity and costs more
than $17 billion dollars annually in the U.S. [15]. Otitis
media is the most common bacterial infection in chil-
dren, and is a major cause for antibiotic prescriptions
[13]. Estimates of the prevalence of dampness or mold
problems in houses are available from multiple sources,
and include the following: at least 20% in European
countries, the U.S., and Canada [2]; 14-40% in Europe,
Russia, and North America [5]; and 50% in the U.S. [21].
L i t t l ee f f e c t i v ep r e v e n t i o ni sc u r r e n t l yp o s s i b l ef o r
human respiratory infections outside of attempting to
avoid contact with or spreading infections, vaccination
for influenza and pneumococcal pneumonia, and possi-
bly specific nutritional supplementation [22]. The few
documented environmental risk factors for respiratory
infections include environmental tobacco smoke [23],
wood or biofuel stoves [24], and low building ventilation
rates [25]. If prevention and remediation of dampness
and mold in houses and other buildings were documen-
ted to substantially reduce some or all types of human
respiratory infections, this would be good and important
news.
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infections in the population associated with dampness
or mold exposure would be estimated, assuming no con-
founding and that RRs approximate ORs, with formula
(2):
A R P P eR R P eR R =− () ⎡ ⎣ ⎤ ⎦ − () + ⎡ ⎣ ⎤ ⎦ 11 1 / (2)
[26] where: Pe is the proportion of the population
exposed.
Based on a proportion of damp/moldy housing in the
population of 20-50% [21], and selected ORs in Table 3,
approximate ARPs would be: for acute bronchitis, 8-
18%; for respiratory infections excluding common cold
and nonspecific upper respiratory infections, 9-20%; and
for respiratory infections in children or infants, 9-19%.
Thus, if exposures related to residential dampness or
mold directly caused respiratory infections, then pre-
venting or remediating all this dampness and mold
would reduce the prevalence of various respiratory
infections by approximately 8-20%.
Thus, this review provides evidence that preventing
or remediating dampness and mold in residences, a
very common condition, may substantially reduce the
burden of respiratory infections. This could be one of
the few available preventive environmental strategies
for these common diseases, now considered mostly
inevitable. In addition, most exacerbations of asthma
have been shown to occur in the presence of viral
respiratory infections [27], and hospitalizations for
severe exacerbations of asthma are strongly associated
with viral infections [28]. This agrees with the finding
that dampness and mold in buildings are associated
consistently with asthma exacerbation [2,3]. Thus,
reduction in viral respiratory infections may have
important dual benefits.
Conclusions
Dampness and mold in buildings are associated with
moderate but statistically significant increases in respira-
tory infections and bronchitis. If these associations were
causal, reducing dampness and mold in buildings would
reduce the occurrence of respiratory infections, the
most common human infections. The results of these
meta-analyses provide support for recommendations by
the Institute of Medicine and WHO to prevent building
dampness and mold problems in buildings, and to take
corrective actions where such problems occur. Addi-
tional focused research is necessary to document
whether these associations are causal, and to develop
more objective assessment tools for dampness, mold, or
various other microbiologic factors that correlate with
human health effects.
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